hVIVO plc (LON:HVO – Get Free Report)’s share price shot up 10% during trading on Tuesday . The stock traded as high as GBX 22 ($0.27) and last traded at GBX 21.25 ($0.26). 7,804,669 shares traded hands during mid-day trading, an increase of 164% from the average session volume of 2,961,263 shares. The stock had previously closed at GBX 19.33 ($0.24).
hVIVO Stock Up 0.4 %
The company has a market cap of £129.85 million, a P/E ratio of 636.17 and a beta of 0.97. The company has a debt-to-equity ratio of 33.86, a current ratio of 1.61 and a quick ratio of 1.16. The stock has a fifty day moving average price of GBX 20.01 and a two-hundred day moving average price of GBX 25.58.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Further Reading
- Five stocks we like better than hVIVO
- What Investors Need to Know About Upcoming IPOs
- Coinbase Gains Momentum on App Store—What It Means for the Stock
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Best Stocks Under $10.00
- 3 Steel Stocks Soaring After Tariff Announcements
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
